Aquedeon Medical was founded with the mission of reducing circulatory arrest time during open cardiothoracic surgery. Our technology, the Duett? Vascular Graft System, was uniquely designed to standardize and simplify open surgical vascular procedures with the goal of providing cardiothoracic surgeons and vascular surgeons a means to treat the target vessels effectively and more efficiently. The Duett Vascular Graft System is currently not approved or cleared for use or distribution in any geography.
Aquedeon Medical的外部链接
452 Oakmead Pkwy
US，California，Sunnyvale，94085
Vice President - Pipeline Strategy | Commercialization | Portfolio & Reimbursement Strategy | Fundraising
Congrats to the team at Aquedeon Medical, Dr Wilson Szeto, and his entire team at University of Pennsylvania Medical Center for a very exciting milestone in cardiothoracic surgery. The potential to use Duett technology to reduce the time the heart is stopped during the procedure is a major step forward! The Society of Thoracic Surgeons https://lnkd.in/gE-dSR7P